UNCERTAINTY around US economic stimulus ahead of a key Federal Reserve meeting weighed on global markets to drag the FTSE 100 Index lower.

Royal Mail workers have voted in favour of boycotting competitors' mail and have massively rejected the Government's controversial plan to privatise the company.

A Bromborough legal service has been selected to provide discounted services to the 90,000 UK membership base of the Royal Institution of Chartered Surveyors.

DISCOVER what's in the Liverpool Post Business Daily today

A COMPANY which offers bespoke microbiological testing has secured £100,000 investment. Perfectus Biomed, based at Sci-Tech Daresbury, received £50,000 from The North West Fund for Biomedical, managed by SPARK Impact, and another £50,000 from venture capital company Midven. Perfectus Biomed specialises in the microbiological testing of biofilm encased bacteria. Persistent biofilm infections have been linked to chronic non-healing wounds, failed medical implants and catheter infections. Perfectus Biomed carries out microbiological testing to help their clients develop antimicrobial and anti-biofilm agents and devices suitable for use in areas including wound care, medical implants, dentistry and contact lenses. The North West Fund for Biomedical is part of the wider £155m North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank. The funding will be used by Perfectus Biomed to expand the company’s research team to meet the growing demand for testing.